Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities: 2013-2025

Historic Total Non-Current Liabilities for Prestige Consumer Healthcare (PBH) over the last 12 years, with Sep 2025 value amounting to $1.6 billion.

  • Prestige Consumer Healthcare's Total Non-Current Liabilities rose 2.02% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 2.02%. This contributed to the annual value of $1.6 billion for FY2025, which is 5.57% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Total Non-Current Liabilities of $1.6 billion as of Q3 2025, which was up 2.62% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Total Non-Current Liabilities registered a high of $2.2 billion during Q3 2021, and its lowest value of $1.5 billion during Q4 2024.
  • In the last 3 years, Prestige Consumer Healthcare's Total Non-Current Liabilities had a median value of $1.6 billion in 2024 and averaged $1.7 billion.
  • In the last 5 years, Prestige Consumer Healthcare's Total Non-Current Liabilities climbed by 3.48% in 2021 and then declined by 15.76% in 2023.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Total Non-Current Liabilities stood at $2.1 billion in 2021, then dropped by 3.69% to $2.1 billion in 2022, then fell by 15.76% to $1.7 billion in 2023, then fell by 11.23% to $1.5 billion in 2024, then climbed by 2.02% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.6 billion during Q1 2025.